ArticleScientific reports2026
Time to Resolution of Diabetic Ketoacidosis and Its Predictors among Adult Diabetic Patients in Public Hospitals of Northeast, Ethiopia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Predictors of Time to Hospital Discharge in Children With New-Onset Diabetic Ketoacidosis in Zambia: A Retrospective Cohort Study.Endocrinology, diabetes & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the discovery and development of diagnostic tests, medications, and technologies, diabetic ketoacidosis remains one of the leading causes of morbidity and mortality among patients with diabetes. Therefore, this study aimed to determine the time to resolution of diabetic ketoacidosis and its predictors among adult diabetic patients in public hospitals of the North Shoa Zone, Northeast Ethiopia. A retrospective follow-up study was conducted among 340 patients with complete medical records from February 1, 2021, to February 1, 2024. Data were analyzed using STATA version 16. Kaplan–Meier survival curves and the log-rank test were used to assess differences in survival among groups. The proportional hazards assumption was evaluated using Schoenfeld residuals, and model fitness was assessed using the Cox–Snell residual test. Cox proportional hazards regression analysis was performed to identify predictors of time to resolution of diabetic ketoacidosis among adult diabetic patients. Variables with a p-value < 0.25 in the bivariable analysis were included in the multivariable model, and predictors were considered statistically significant at p < 0.05 with a 95% confidence interval. The median time to resolution of diabetic ketoacidosis (DKA) among the 340 participants was 14 h (95% CI: 13–16). Age groups 45–54 years (AHR = 0.47; 95% CI: 0.28–0.79) and ≥ 55 years (AHR = 0.24; 95% CI: 0.12–0.45), moderate DKA (AHR = 0.23; 95% CI: 0.16–0.32), severe DKA (AHR = 0.10; 95% CI: 0.06–0.17), and initial random blood sugar > 500 mg/dL (AHR = 0.49; 95% CI: 0.36–0.65) were significantly associated with a slower time to DKA resolution. In contrast, having type 2 diabetes mellitus (AHR = 4.20; 95% CI: 2.42–7.34), a duration of diabetes mellitus > 5 years (AHR = 6.65; 95% CI: 2.50–17.76), and not being newly diagnosed (AHR = 6.45; 95% CI: 2.42–17.18) were significantly associated with a faster time to DKA resolution. The median time to resolution of diabetic ketoacidosis (DKA) was 14 h. Age greater than 45 years, moderate to severe diabetic ketoacidosis, high initial blood glucose levels, and newly diagnosed diabetes were associated with slower resolution. In contrast, type 2 diabetes, duration of diabetes mellitus greater than 5 years, and not being newly diagnosed were associated with faster resolution. Consequently, early risk stratification and targeted management may improve DKA outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.